New Targeted Radiopharmaceutical Therapy Achieves Remission in Pancreatic Cancer Model
A groundbreaking advancement in the field of targeted radiopharmaceutical therapy heralds a new era for treating pancreatic ductal adenocarcinoma (PDAC), ...
A groundbreaking advancement in the field of targeted radiopharmaceutical therapy heralds a new era for treating pancreatic ductal adenocarcinoma (PDAC), ...
In the relentless battle against pancreatic ductal adenocarcinoma (PDAC), a notoriously aggressive and treatment-resistant cancer, researchers have uncovered a groundbreaking ...
PHOENIX, Ariz. — April 30, 2025 — HonorHealth Research Institute’s new downtown Phoenix laboratory has produced its first study, centered ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine